We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
Cap. Flow
-$915M
Cap. Flow %
-1.97%
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$170M
2
T icon
AT&T
T
+$142M
3
MSFT icon
Microsoft
MSFT
+$136M
4
XLNX
Xilinx Inc
XLNX
+$110M
5
AMZN icon
Amazon
AMZN
+$86.9M

Sector Composition

Rank Sector Weight
1 Technology 31.53%
2 Consumer Discretionary 13.24%
3 Communication Services 9.89%
4 Healthcare 9.39%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
2176
Ardelyx
ARDX
$1.24B
$19K ﹤0.01%
18,117
-2,991
-14% -$2.67K
VHC icon
2177
VirnetX Holding Corp
VHC
$52.3M
$19K ﹤0.01%
595
-98
-14% -$4K
FBIO icon
2178
Fortress Biotech
FBIO
$111M
$18K ﹤0.01%
917
-167
-15% -$4.57K
KLTR icon
2179
Kaltura
KLTR
$211M
$18K ﹤0.01%
+10,307
New +$28.3K
PAVM icon
2180
PAVmed
PAVM
$33.9M
$18K ﹤0.01%
30
-5
-14% -$3.72K
LOTZ
2181
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$18K ﹤0.01%
13,420
-2,215
-14% -$4.18K
QTNT
2182
DELISTED
Quotient Limited Ordinary Shares
QTNT
$18K ﹤0.01%
373
-56
-13% -$3.35K
IBIO icon
2183
iBio
IBIO
$71M
$17K ﹤0.01%
81
-13
-14% -$2.72K
TRVN
2184
DELISTED
Trevena, Inc.
TRVN
$17K ﹤0.01%
49
-8
-14% -$2.52K
AMPE
2185
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$17K ﹤0.01%
122
-20
-14% -$2.92K
TECX
2186
Tectonic Therapeutic
TECX
$573M
$16K ﹤0.01%
968
-234
-19% -$4.84K
LITS
2187
Lite Strategy Inc
LITS
$33.6M
$15K ﹤0.01%
1,199
+15
+1% +$589
UAVS icon
2188
AgEagle Aerial Systems
UAVS
$41.4M
$15K ﹤0.01%
13
-2
-13% -$2.36K
SEEL
2189
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$15K ﹤0.01%
5
-1
-17% -$4.3K
NBEV
2190
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$15K ﹤0.01%
25,222
-4,169
-14% -$2.98K
MREO
2191
Mereo BioPharma
MREO
$45.9M
$14K ﹤0.01%
12,056
-3,590
-23% -$4.64K
AWH
2192
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$14K ﹤0.01%
909
-150
-14% -$2.6K
HOFV
2193
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$12K ﹤0.01%
475
-78
-14% -$2.01K
LVO icon
2194
LiveOne
LVO
$66M
$9K ﹤0.01%
1,142
-147
-11% -$1.28K
AVTX icon
2195
Avalo Therapeutics
AVTX
$976M
$8K ﹤0.01%
4
-1
-20% -$2.51K
ACIU icon
2196
AC Immune
ACIU
$227M
-11,230
Closed -$56K
ACTG icon
2197
Acacia Research
ACTG
$450M
-10,714
Closed -$55K
AGYS icon
2198
Agilysys
AGYS
$2.78B
-5,254
Closed -$234K
AKRO
2199
DELISTED
Akero Therapeutics
AKRO
-10,529
Closed -$223K
ALDX icon
2200
Aldeyra Therapeutics
ALDX
$91.7M
-10,602
Closed -$43K

Similar funds

ProShare Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
  • ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
  • ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
  • ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
  • ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
  • ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
  • ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.